Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CTi Biopharma Corp (NASDAQ:CTIC)

2.53
Delayed Data
As of Dec 13
 -0.04 / -1.56%
Today’s Change
2.52
Today|||52-Week Range
6.48
-37.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$110.4M

Company Description

CTI BioPharma Corp. operates as a biopharmaceutical company, which is focuses on the development, acquisition, and commercialization of novel treatments for cancer. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Contact Information

CTI BioPharma Corp.
3101 Western Avenue
Seattle Washington 98121
P:(206) 282-7100
Investor Relations:
(206) 272-4345

Employees

Shareholders

Other institutional40.07%
Mutual fund holders2.55%
Individual stakeholders12.91%

Top Executives

Adam R. CraigPresident, Chief Executive Officer & Director
Bruce J. SeeleyCOO, Secretary, Chief Administrative Officer & EVP
David H. KirskeChief Financial Officer
Jack W. SingerEVP, Chief Scientific & Medical Officer
Ed BellInvestor Relations Contact